Addus HomeCare (ADUS) Stock Forecast & Price Target

→ Emergency: Biden's $20 Trillion Mistake Could Cost YOU! (From GoldenCrest Metals) (Ad)

$96.17

-0.45 (-0.47%)

(As of 02:25 PM ET)

Addus HomeCare Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Moderate Buy
Based on 7 Analyst Ratings

Analysts' Consensus Price Target

$103.83
7.97% Upside

High Forecast	$118.00
Average Forecast	$103.83
Low Forecast	$88.00

Type	Current Forecast 4/19/23 to 4/18/24	1 Month Ago 3/20/23 to 3/19/24	3 Months Ago 1/19/23 to 1/19/24	1 Year Ago 4/19/22 to 4/19/23
Consensus Rating	Moderate Buy	Moderate Buy	Buy	Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	6 Buy rating(s)	6 Buy rating(s)	5 Buy rating(s)	4 Buy rating(s)
Hold	1 Hold rating(s)	1 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$103.83	$103.83	$107.00	$119.25
Predicted Upside	7.97% Upside	14.45% Upside	23.40% Upside	22.74% Upside

Get Addus HomeCare Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for ADUS and its competitors with MarketBeat's FREE daily newsletter.

Ad The Freeport Society

Next President (Not Trump. Not Biden.)

Do you want to see who I believe will be the next president of the U.S.A? It won't be Biden… And it won't be Trump.

Click here to see why it will be _______________.

ADUS Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ADUS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Addus HomeCare Stock vs. The Competition

Type	Addus HomeCare	Medical Companies	S&P 500
Consensus Rating Score	2.86	2.68	2.49
Consensus Rating	Moderate Buy	Moderate Buy	Hold
Predicted Upside	7.47% Upside	934.49% Upside	12.27% Upside
News Sentiment Rating	Positive News	Neutral News	Positive News

Recent Analyst Ratings and Stock Forecasts

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Action	Rating	Price Target	Upside/Downside on Report Date
3/26/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$118.00	+15.03%
3/6/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Equal Weight	$88.00	-9.92%
2/29/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$102.00	+10.62%
2/5/2024	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform
12/12/2023	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$105.00	+13.37%
11/1/2023	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$110.00 ➝ $105.00	+31.99%
8/2/2023	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Outperform ➝ Outperform	$100.00 ➝ $105.00	+12.98%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 02:46 PM ET.

ADUS Price Target - Frequently Asked Questions

What is Addus HomeCare's consensus rating and price target?: According to the issued ratings of 7 analysts in the last year, the consensus rating for Addus HomeCare stock is Moderate Buy based on the current 1 hold rating and 6 buy ratings for ADUS. The average twelve-month price prediction for Addus HomeCare is $103.83 with a high price target of $118.00 and a low price target of $88.00. Learn more on ADUS's analyst rating history.
Do Wall Street analysts like Addus HomeCare more than its competitors?: Analysts like Addus HomeCare more than other Medical companies. The consensus rating score for Addus HomeCare is 2.86 while the average consensus rating score for medical companies is 2.68. Learn more on how ADUS compares to other companies.
Does Addus HomeCare's stock price have much upside?: According to analysts, Addus HomeCare's stock has a predicted upside of 11.73% based on their 12-month stock forecasts.

What analysts cover Addus HomeCare?: Addus HomeCare has been rated by Barclays, Oppenheimer, Royal Bank of Canada, and William Blair in the past 90 days.

Stock Ratings Reports and Tools

Related Companies:

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

This page (NASDAQ:ADUS) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Addus HomeCare (ADUS) Stock Forecast & Price Target

Addus HomeCare Consensus Analyst Rating and Stock Price Forecast (2024)

Analysts' Consensus Rating

Analysts' Consensus Price Target

ADUS Analyst Ratings By Month

ADUS Price Targets by Month

Addus HomeCare Stock vs. The Competition

Recent Analyst Ratings and Stock Forecasts

ADUS Price Target - Frequently Asked Questions

Stock Ratings Reports and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info